Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-04-03
2007-04-03
Slobodyansky, Elizabeth (Department: 1652)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S006120, C435S252300, C435S320100, C530S350000
Reexamination Certificate
active
10490463
ABSTRACT:
Disclosed herein are novel polynucleotides encoding one of a uracil transport protein and a uracil phosphoribosyl transferase, each being derived fromSalmonella typhimurium.The disclosed uracil phosphoribosyl transferase protein is useful in sensitizing human cancer cells to treatment with anti-cancer agents such as 5-Fluorouracil.
REFERENCES:
patent: 4394448 (1983-07-01), Szoka, Jr. et al.
patent: 4399216 (1983-08-01), Axel et al.
patent: 4405712 (1983-09-01), Vande Woude et al.
patent: 4619794 (1986-10-01), Hauser
patent: 4634665 (1987-01-01), Axel et al.
patent: 4650764 (1987-03-01), Temin et al.
patent: 5858707 (1999-01-01), Guimaraes et al.
patent: WO 01/70955 (2001-09-01), None
patent: WO 02/77183 (2002-10-01), None
Andersen et al.,“Characterization of theuppgene encoding uracil phosphoribosyltransferase ofEscherichia coliK12”, Eur. J. Biochem., 204:51-56 (1992).
Molloy, A., et al., “Uridine-5′ Monophosphate Pyrophosphorylase Activity FromEscherichia Coli”, FEBS Letts., 5(3):211-213 (1969).
Kern et al.,“TheFURIgene ofSaccharomyces cerevisiae: cloning, structure and expression of wild-type and mutant alleles”, Gene, 88:149-157 (1990).
Kawamura, K. et al., “Expression ofEscherichia coliuracil phosphoribosyltransferase gene in murine colon carcinoma cells augments the antitumoral effect of 5-fluorouracil and induces protectiev immunity”, Cancer Gene Therapy, 7(4):637-643 (2000).
Sunamura, M. et al., “Development of gene therapy for pancreatic cancer”, Nippon Rinsho, 59:(1)98-103 (2001).
Inaba, M. et al., “Circumvention of 5-Fluorouracil Resistance in Human Stomach Cancer4 Cells by Uracil Phosphoribosyltransferase Gene Transduction”, Japan J. Cancer Res., 90:349-354 (1999).
Kanai et al., “Adenovirus-mediated Transduction ofEscherichia coliUracil Phosphoribosyltransferase Gene Sensitizes Cancer Cells to Low Concentrations of 5-Fluorouracil”, Cancer Research, 58:1946-1951 (1998).
Beaucage & Carruthers, “Deoxynucleoside Phosphoramidites—A New Class of Key Intermediates for Deoxypolynucleotide Synthesis”, Tetrahedron Letters, 22(20):1859-1862 (1981).
Denhardt, David T., “A Membrane-Filter Technique for the Detection of Complementary DNA”, Biochemical and Biophysical Research Communications, 23(5):641 (1966).
Friedmann, Theodore; “Progress Toward Human Gene Therapy”, Science, 244:1275-1281 (1989).
Okayama & Berg, “High-Efficiency Cloning of Full-Length cDNA”, Molecular and Cellular Biology, 2(2):161-170 (1982).
Wong et al., Genetics Institute, “Human GM-CSF: Molecular Cloning of the Complementary DNA and Purification of the Natural and Recombinant Proteins”, Science, 228:810-815 (1985).
Urlaub et al., “Effect of Gamma Rays at the Dihydrofolate Reductase Locus: Deletions and Inversions”, Somatic Cell Molecular Genetics, 12(6):555-566 (1986).
Bahouth et al., “Immunological approaches for probing receptor structure and function”, Trends Pharmacol. Science, 12:338-343 (1991).
Kinsella et al., “Resistance to chemotherapeutic antimetabolites: a functon of salvage pathway involvement and cellular response to DNA damage”, British Journal of Cancer, 75(7):935-945 (1997).
Grove et al., “Uptake and Metabolism of the New Anticancer Compound β-L-(-)-Dioxolane-Cytidine in Human Prostate Carcinoma DU-145 Cells”, Cancer Research, 56: 4187-4191, 1996.
Griffith et al., “Nucleoside and nucleobase transport systems of mammalian cells”, Biochimica et Biophysica Acta, 1286(3): 153-181, 1996.
Jund et al., “Primary structure of the uracil transport protein ofSaccharomyces cerevisiae”, European Journal of Biochemistry, 171(1-2): 417-424, 1988.
McClelland et al., “Complete genome sequence ofSalmonella entericaserovar Typhimurium LT2”, Nature, 413:852-856, 2001.
Molchan, O.K. et al., “Isolation and Initial Characterization of the Uridine Phosphorylase fromSalmonella typhimurium”, Biochemistry (Moscow), 63(2):195-199, 1998.
Andersen, Paal Skytt et al., “Uracil Uptake inEscherichia coliK-12: Isolation ofuraAMutants and Cloning of the Gene”, Journal of Bacteriology, 177(8):2008-2013, 1995.
Bork, P. et al., “Predicting Function: From Genes to Genomes and Back”, Journal of Molecular Biology, 283(4):707-725, 1998.
Database GenBank Accession No. STU68765, Sep. 26, 1996.
Kawamura, Kiyoko et al., “Expression ofEscherichia coliuracil phosphoribosyltransferase gene in murine colon carcinoma cells augments the antitumoral effect of 5-fluorouracil and induces protective immunity”, Cancer Gene Therapy, 7(4):637-643, 2000.
Database GenBank Accession No. AAS56214, Mar. 14, 2004.
Database GenBank Accession No. AAU38356, Sep. 17, 2004.
Parkhill, J. et al., “Complete genome sequence of a multiple drug resistantSalmonella entericaserovar Typhi CT18”, Nature, 413:848-852, 2001.
Glaab Warren
Skopek Thomas
Giesser Joanne M.
Kohli Vineet
Slobodyansky Elizabeth
LandOfFree
Isolated nucleic acid molecules encoding a bacterial uracil... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated nucleic acid molecules encoding a bacterial uracil..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated nucleic acid molecules encoding a bacterial uracil... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3801118